Latest filing published 04 Jan 2018 for Capricor Therapeutics, INC., €2,800.
Insider track record
Rachel Smith: trading record in brief
Rachel Smith is a declared insider of Capricor Therapeutics, Inc., with filings sourced from SEC (Form 4). Altogether 2 filings, all relating to 22 December 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 4 January 2018, the filings show an option exercise worth €2,800 in Capricor Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rachel Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,748 shares@ US$0.1650.0% of flowCommon StockSEC:0001144204-18-000868:0
- 2,244 shares@ US$1.4850.0% of flowCommon StockSEC:0001144204-18-000868:1
2 of 2 declarations
